Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Institutional Investor > Flagship Ventures Fund Iv General Partner Llc > Profile

Instuitional Investor - Flagship Ventures Fund Iv General Partner Llc

Profile
13F Holdings

Fund Profile

Filing Period:

Fund Name:	Flagship Ventures Fund Iv General Partner Llc
Portfolio Value	$584,904,000

Top 13F Holdings

Filing Period:

No.	Security	Ticker	Shares	Value	% Port
1.	Seres Therapeutics Inc.	MCRB	634,143.8	$368,438,000	62.99%
2.	Editas Medicine Inc.	EDIT	4,955,316	$120,910,000	20.67%
3.	Syros Pharmaceuticals Inc.	SYRS	480,665.6	$87,241,000	14.91%
4.	T2 Biosystems Inc.	TTOO	148.351	$5,852,000	1%
5.	Eleven Biotherapeutics Inc		1,466,417	$2,464,000	0.42%